221 related articles for article (PubMed ID: 22958404)
1. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
Chen X; Li J; Li M; Zeng M; Li T; Xiao W; Li J; Wu Q; Ke X; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2013 Mar; 15(3):224-33. PubMed ID: 22958404
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
Huang J; Li X; Li M; Li S; Xiao W; Chen X; Cai M; Wu Q; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2012 Jul; 14(7):644-53. PubMed ID: 22340191
[TBL] [Abstract][Full Text] [Related]
3. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment.
Xu XH; Zhao C; Peng Q; Xie P; Liu QH
Braz J Med Biol Res; 2017 Mar; 50(3):e5396. PubMed ID: 28273207
[TBL] [Abstract][Full Text] [Related]
4. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
5. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
6. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
Long L; Li Y; Yu S; Li X; Hu Y; Long T; Wang L; Li W; Ye X; Ke Z; Xiao H
J Diabetes Res; 2019; 2019():4875421. PubMed ID: 31976335
[TBL] [Abstract][Full Text] [Related]
7. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.
Jiao W; Ji JF; Xu W; Bu W; Zheng Y; Ma A; Zhao B; Fan Q
Sci Rep; 2019 Oct; 9(1):15339. PubMed ID: 31653890
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effect of KH902 on retinal neovascularization.
Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
10. Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.
Zhang M; Zhang J; Yan M; Li H; Yang C; Yu D
Mol Vis; 2008 Jan; 14():37-49. PubMed ID: 18246030
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
12. Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.
Du L; Peng H; Wu Q; Zhu M; Luo D; Ke X; Yang P; Lei B
Mol Vis; 2015; 21():185-93. PubMed ID: 25737631
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin represses neovascularization in diabetic retinopathy.
Shao J; Yao Y
Mol Vis; 2016; 22():1188-1197. PubMed ID: 27746673
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway.
Wang D; Wang L; Gu J; Yang H; Liu N; Lin Y; Li X; Shao C
J Cardiovasc Pharmacol; 2014 Sep; 64(3):218-27. PubMed ID: 25192544
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A1 suppresses the hypoxia-induced angiogenesis of human retinal endothelial cells by targeting PlGF.
Hu J; Chen ZT; Su KY; Lian Y; Lu L; Hu AD
Int J Ophthalmol; 2023; 16(1):33-39. PubMed ID: 36659935
[TBL] [Abstract][Full Text] [Related]
17. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
18. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
[TBL] [Abstract][Full Text] [Related]
19. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
Wang XL; Xian Y; Chen XL
Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
